Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

9.85USD
12 Dec 2017
Change (% chg)

-- (--)
Prev Close
$9.85
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
30,537
52-wk High
$15.75
52-wk Low
$5.48

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Buy -0.13 April 13 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 1 1
(2) OUTPERFORM 0 0 0 0
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.00 1.00 1.00 1.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Jan-18 1 5.40 5.40 5.40 --
Quarter Ending Apr-18 1 5.30 5.30 5.30 --
Year Ending Apr-18 1 12.20 12.20 12.20 --
Year Ending Apr-19 1 14.40 14.40 14.40 --
Earnings (per share)
Quarter Ending Jan-18 1 -0.13 -0.13 -0.13 --
Quarter Ending Apr-18 1 -0.16 -0.16 -0.16 --
Year Ending Apr-18 1 -1.21 -1.21 -1.21 --
Year Ending Apr-19 1 -1.40 -1.40 -1.40 --

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Jun-16 0.00 0.01 0.01 0.00
Quarter Ending Mar-16 0.00 0.01 0.01 0.00
Quarter Ending Dec-15 0.00 0.01 0.01 344.44
Quarter Ending Sep-15 0.00 0.01 0.01 288.89
Quarter Ending Jun-15 0.00 0.01 0.00 204.35

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Jan-18 5.40 5.40 5.40 0.10 --
Quarter Ending Apr-18 5.30 5.30 5.30 0.10 --
Year Ending Apr-18 12.20 12.20 12.20 0.30 --
Year Ending Apr-19 14.40 14.40 14.40 0.30 --

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Jan-18 0 0 0 0
Quarter Ending Apr-18 0 0 0 0
Year Ending Apr-18 0 0 0 0
Year Ending Apr-19 0 0 0 0
Earnings